Skip to main content
SpringerLink
Log in

Periphere Neuropathie

  • Chapter
Medikamentös induzierte neurologische und psychiatrische Störungen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • ADRAC — Adverse Drug Reactions Advisory Committee (1993) Paresthesia and neuropathy with hypolipidaemic agents. Aust Adver Drug React Bullet 12:6

    Google Scholar 

  • Aghajanian C, Soignet S, Dizon et al. (2002) A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res 8: 2505–2511

    PubMed  CAS  Google Scholar 

  • Ahmad S (1995) Lovastatin and peripheral neuropathy. Am Heart J 130: 1321

    PubMed  CAS  Google Scholar 

  • Alberts DS, Noel JK (1995) Cisplatin-associated neurotoxicity: can it be prevented? Anticancer Drugs 6: 369–383

    PubMed  CAS  Google Scholar 

  • Allen MB, Prowse K (1989) Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo. Thorax 44: 292–297

    Article  PubMed  CAS  Google Scholar 

  • Anderson NE, Lynch N, O’Brien KP (1985) Disabling complications of amiodarone. Aust NZ J Med 15:300–305

    CAS  Google Scholar 

  • Ansbacher LE, Bosch EP, Cancilla PA (1982) Disulfiram neuropathy: a neurofilamentous distal axonopathy. Neurology 32: 424–428

    PubMed  CAS  Google Scholar 

  • Argyriou AA, Chroni E, Koutras A, Ellul J, Papapetropoulos G, Iconomou G, Kalofonos HP (2005) Vitamin E for prophylaxis against chemotherapy-induced neuropathy. A randomized controlled trial. Neurology 64: 26–31

    PubMed  CAS  Google Scholar 

  • Bent MJ van den, van Raaij-van den Aarssen VJ, Verweij J, Doom PA, Sillvis Smitt PA (1997) Progression of paclitaxel-induced neuropathy following discontinuation of treatment. Muscle Nerve 20: 750–752

    PubMed  Google Scholar 

  • Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, Soo W (1993) 2′,3′-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43: 358–362

    PubMed  CAS  Google Scholar 

  • Bergouignan FX, Vital C, Henry P, Eschapasse P (1988) Disulfiram neuropathy. J Neurol 235: 382–383

    Article  PubMed  CAS  Google Scholar 

  • Biehl JP, Vilter R (1954) Effect of isoniazid on vitamin B6 metabolism. Its possible significance in producing isoniazid neuritis. Proc Soc Exp Biol Med 185: 389

    Google Scholar 

  • Blondel M, Arnott G, Defoort S, Bouchez B, Persuy P, Masingue M, Hache JC, Krivosic I (1986) 11 cases of neuropathy induced by almitrine, of which one has optic neuropathy. Rev Neurol 142: 683–688

    PubMed  CAS  Google Scholar 

  • Bouche P, Bousser MG, Peytour MA, Cathala HP (1979) Perhexiline maleate and peripheral neuropathy. Neurology 29: 739–743

    PubMed  CAS  Google Scholar 

  • Bouche P, Lacomblez L, Leger JM et al. (1989) Peripheral neuropathies during treatment with almitrine: report of 46 cases. J Neurol 236: 29–33

    Article  PubMed  CAS  Google Scholar 

  • Bousser MG, Bouche P, Brochard C et al. (1976) Neuropathies peripheriques au malate de perhexiline. A propos de 7 observations. Coer Med Interne 15: 181

    CAS  Google Scholar 

  • Boyce EG, Cookson ET, Bond WS (1990) Persistent metronidazole-induced peripheral neuropathy. DICP 24: 19–21

    PubMed  CAS  Google Scholar 

  • Bradley WG, Karlsson I, Rassol L (1977) Metronidazole neuropathy. BMJ 2: 610

    PubMed  CAS  Google Scholar 

  • Brew B, Tisch S, Law M (2003) Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy. AIDS 17: 1094–1096

    Article  PubMed  Google Scholar 

  • Brust JC, Hammer JS, Challenor Y, Healton EB, Lessner RP (1979) Acute generalized poly-neuropathy accompanying lithium poisoning. Ann Neurol 6: 360–362

    Article  PubMed  CAS  Google Scholar 

  • Calabrese L, Fleischer AB (2000) Thalidomide: current and potential clinical applications. Am J Med 108:487–495

    Article  PubMed  CAS  Google Scholar 

  • Casarino JP (1977) Neuropathy associated with amitriptyline. Bilateral footdrop. NY State J Med 77: 2144–2146

    Google Scholar 

  • Casey EB, Jellife AM, LeQuesne PM, Millett YL (1973) Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96: 69–86

    PubMed  CAS  Google Scholar 

  • Chamess M, Morady F, Scheinmann M (1984) Frequent neurologic toxicity associated with amiodarone therapy. Neurology 34: 669

    Google Scholar 

  • Comblath DR, McArthur JC (1988) Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 38: 794–796

    Google Scholar 

  • Coxon A, Pallis CA (1976) Metronidazole neuropathy. J Neurol Neurosurg Ps 39: 403–405

    CAS  Google Scholar 

  • Dano P, Tammam D, Brosset C, Bregigeon M (1996) Peripheral neuropathies caused by disulfiram. Rev Neurol 152: 294–295

    PubMed  CAS  Google Scholar 

  • Dillmann U, Kramer G, Goebel HH (1991) Polyneuropathie in Duhring dermatitis herpetiformis. Nervenarzt 62: 516–518

    PubMed  CAS  Google Scholar 

  • Dobkin BH (1977) Reversible subacute peripheral neuropathy induced by phenytoin. Arch Neurol 34: 189–190

    PubMed  CAS  Google Scholar 

  • Ellis FG (1962) Acute polyneuritis after nitrofurantoin therapy. Lancet 2: 1136

    Google Scholar 

  • Emir S, Kutluk T, Chan KW, Yalcin B, Varli K, Buyukpamkcu M (1999) Peripheral neuropathy during alpha-interferon therapy in a child with Hogkin’s disease. Pediatr Hematol Oncol 16: 557–560

    Article  PubMed  CAS  Google Scholar 

  • Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff NB (1987) Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med 82: 447–455

    Article  PubMed  CAS  Google Scholar 

  • Fam AG, Gordon DA, Sarkozi J, Blair GR, Cooper PW, Harth M, Lewis AJ (1984) Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol 11: 700–706

    PubMed  CAS  Google Scholar 

  • Finkelman I, Arief AJ (1942) Untoward effects of phenytoin sodium in epilepsy. JAMA 118: 1209–1212

    CAS  Google Scholar 

  • Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM (1997) Prospective study of paclitaxel-induced peripheral neuropathy with quantative sensory testing. J Neurooncol 35: 47–53

    Article  PubMed  CAS  Google Scholar 

  • Fraser AG, McQueen I, Watts A et al. (1985) Peripheral neuropathy during long-term high-dose amiodarone therapy. J Neurol Neurosurg Ps 48: 576

    CAS  Google Scholar 

  • Fraser DM, Campbell IW, Miller HC (1977) Peripheral and autonomic neuropathy after treatment with perhexiline maleate. BMJ 3: 675–676

    Google Scholar 

  • Frisoni GB, Di Monda V (1989) Disulfiram neuropathy: a review (1971 —1988) and report of a case. Alcohol 24: 429–437

    CAS  Google Scholar 

  • Fullerton PM, O’sullivan DJ (1968) Thalidomide neuropathy: a clinical, electrophysiological, and histological follow-up study. J Neurol Neurosurg Ps 31: 543–551

    CAS  Google Scholar 

  • Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, Sindrup SH (2002) Statins and risk of polyneuropathy. A case-control study. Neurology 58: 1333–1337

    PubMed  CAS  Google Scholar 

  • Gastineau DA, Habermann TM, Hermann C (1989) Severe neuropathy associated with low-dose recombinant interferon-alpha. Am J Med 87: 116

    Article  PubMed  CAS  Google Scholar 

  • Gardner-Thorpe C, Benjamin S (1971) Peripheral neuropathy after disulfiram administration. J Neurol Neurosurg Ps 34: 253–259

    CAS  Google Scholar 

  • Gherardi R, Louarn F, Benvenuti C et al. (1985) Peripheral neuropathy in patients treated with almitrine dimesylate. Lancet 1: 1247–1250

    PubMed  CAS  Google Scholar 

  • Gherardi R, Baudrimont M, Gray F, Louarn F (1987) Almitrine neuropathy. A nerve biopsy study of 8 cases. Acta Neuropathol 73: 202–208

    Article  PubMed  CAS  Google Scholar 

  • Gregg RW, Molepo JM, Monpetit VJ, Mikael NZ, Redmond D, Gadia M, Stewart DJ (1992) Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10: 795–803

    PubMed  CAS  Google Scholar 

  • Grünberg SM, Sonka S, Stevenson LL, Muggia FM (1989) Progressive paresthesias after cessation of therapy with very high-dose cisplatin. Cancer Chemother Pharmacol 25: 62–64

    PubMed  Google Scholar 

  • Gutman L, Martin JD, Welton W (1976) Dapsone motor neuropathy — an axonal disease. Neurology 26:514–516

    Google Scholar 

  • Hilkens PH, Pronk LC, Verweij J, Vecht CJ, Putten WL van, Bent MJ van den (1997) Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin. Br J Cancer 75: 417–422

    PubMed  CAS  Google Scholar 

  • Hilleman D, Miller MA, Parker R, Doering P, Pieper JA (1998) Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 18: 138S–145S

    PubMed  CAS  Google Scholar 

  • Holmberg L, Bomann G, Bottiger LE, Eriksson B, Spross R, Wessling A (1980) Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 69: 733–738

    Article  PubMed  CAS  Google Scholar 

  • Horowitz JD, Sia ST, Macdonald PS, Goble AJ, Louis WJ (1986) Perhexiline maleate treatment for severe angina pectoris — correlations with pharmacokinetics. Int J Cardiol 13: 219–229

    Article  PubMed  CAS  Google Scholar 

  • Isaacs AD (1963) Peripheral neuropathy after amitriptyline. BMJ 1: 1739

    Google Scholar 

  • Jacobs MB (1994) HMG-CoA reductase inhibitor therapy and peripheral neuropathy. Ann Intern Med 120: 970

    PubMed  CAS  Google Scholar 

  • Jacobs J, Costa-Jussa FR (1985) The pathology of amiodarone neurotoxicity II. Peripheral neuropathy in man. Brain 108: 753

    PubMed  Google Scholar 

  • Jeppesen U, Gaist D, Smith T, Sindrup SH (1999) Statins and peripheral neuropathy. Eur J Clin Pharmacol 54: 835–838

    Article  PubMed  CAS  Google Scholar 

  • Johnston SR, Burn D, Brooks DJ (1991) Peripheral neuropathy associated with lithium toxicity. J Neurol Neurosur Ps 54: 1019–1020

    CAS  Google Scholar 

  • Katrak SM, Pollock M, O’Brien CP, Nukada H, Allpress S, Calder C, Palmer DG, Grennan DM, McCormack PL, Laurent MR (1980) Clinical and morphological features of gold neuropathy. Brain 103: 671–693

    PubMed  CAS  Google Scholar 

  • Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC (1999) Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res 19: 83–88

    PubMed  CAS  Google Scholar 

  • Klugkist H, Preuss S (1992) Disulfiram Neuropathie. Dtsch Med Wochenschr 117: 1278–1282

    PubMed  CAS  Google Scholar 

  • Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F (1992) Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr 5: 60–64

    PubMed  CAS  Google Scholar 

  • Kondagunta GV, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, Mazumdar M, Motzer RJ (2004) Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol 22: 3720–3725

    Article  PubMed  CAS  Google Scholar 

  • Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaburg W, Krarup C (1993) Examination of distal involvement in cisplatin-induced neuropathy in man. An elctrophysiological and histological study with particular reference to to touch receptor function. Brain 116: 1017–1041

    PubMed  Google Scholar 

  • Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H (1999) Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 25: 29–40

    Article  PubMed  CAS  Google Scholar 

  • LaCivita L, Zignego AL, Lombardini F, Monti M, Longombardo G, Pasero G, Ferri C (1996) Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinaemia and hepatitis B virus infection. J Rheumatol 23: 1641–1643

    CAS  Google Scholar 

  • Legha SS (1986) Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol 1: 421–427

    PubMed  CAS  Google Scholar 

  • Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417–422

    PubMed  CAS  Google Scholar 

  • LeWitt PA, Forno LS (1985) Peripheral neuropathy following amitriptyline overdose. Muscle Nerve 8: 723–724

    PubMed  CAS  Google Scholar 

  • Leys D, Pasquier F, Lamblin M et al (1987) Acute polyradiculoneuropathy after amitriptyline overdose. BMJ 294: 608

    PubMed  CAS  Google Scholar 

  • Licht RW, Smith D, Braendgaard H (1997) The effect of chronic lithium treatment on the calibre of axons and nerve fibres in the rat sural nerve. Eur Neuropsychopharmacol 7: 95–98

    Article  PubMed  CAS  Google Scholar 

  • Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger JM, Piette JC (1999) Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 23: 403–406

    PubMed  CAS  Google Scholar 

  • Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39: 368–373

    PubMed  CAS  Google Scholar 

  • LoMonaco M, Milone M, Batocchi AP, Padua L, Restuccia D, Tonalli P (1992) Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol 239: 199–204

    Article  PubMed  CAS  Google Scholar 

  • Loughridge LW, Belf MB (1962) Peripheral neuropathy due to nitrofurantoin. Lancet 2:1133

    Google Scholar 

  • Maki RG, Kraft AS, Scheu K, Yamada J, Wadler S, Antonescu CR, Wright JJ, Schwartz GK (2005) A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas. Cancer 103: 1431–1438

    Article  PubMed  CAS  Google Scholar 

  • Manji H (2000) Neuropathy in HIV infection. Curr Opin Neurol 13: 589–592

    PubMed  CAS  Google Scholar 

  • Martinez-Arizala A, Sobol S, McCarty GE, Nichols BR, Rakita L (1983) Amiodarone neuropathy. Neurology 33: 643–645

    PubMed  CAS  Google Scholar 

  • Mayr N, Graninger W, Wessely P (1983) Eine chemisch-induzierte Polyneuropathie bei chronischer Polyarthritis behandelt mit D-Penicillamin? Wien Klin Wochenschr 95: 86–88

    PubMed  CAS  Google Scholar 

  • McGuire SA, Gospe SM, Dahl G (1989) Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Med Pediatr Oncol 17: 520–523

    Article  PubMed  CAS  Google Scholar 

  • McLachlan R, Brown W (1995) Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Can J Sci 22: 50

    CAS  Google Scholar 

  • McLeod JG, Penny R (1969) Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Ps 32: 297–304

    CAS  Google Scholar 

  • Mehrotra TN, Srivastava SS, Goel VK, Sood K, Singh VS, Jain AK (1992) A study of nerve conduction velocity in patients on diphenylhydantoin therapy. J Assoc Physicians India 40: 619–620

    PubMed  CAS  Google Scholar 

  • Moddel G, Bilbao JM, Payne D, Ashby P (1978) Disulfiram neuropathy. Arch Neurol 35:658–660

    PubMed  CAS  Google Scholar 

  • Mokri B, Ohnishi A, Dyck PJ (1981) Disulfiram neuropathy. Neurology 31: 730–735

    PubMed  CAS  Google Scholar 

  • Moore RD, Wong WM, Keruly JC, McArthur JC (2000) Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 14: 273–278

    Article  PubMed  CAS  Google Scholar 

  • Moyle GJ, Sadler M (1998) Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf 19: 481–494

    PubMed  CAS  Google Scholar 

  • Myers JB, Ronthal M (1978) Perhexiline maleate neurotoxicity and weight loss. Med J Aust 2: 465–466

    PubMed  CAS  Google Scholar 

  • Neundörfer B (1992) Neurologische Begleiterkrankungen des M. Crohn. Fortschr Neurol Psychiat 60:481–486

    PubMed  Google Scholar 

  • Nukada H, Pollock M (1981) Disulfiram neuropathy. A morphometric study of sural nerve. J Neurol Sci 51:51–67

    Article  PubMed  CAS  Google Scholar 

  • Nisar M, Watkin SW, Bucknall RC, Agnew RA (1990) Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Thorax 45: 419–420

    PubMed  CAS  Google Scholar 

  • Ochonisky S, Verroust J, Bastuji-Garin S, Gherardi R, Revuz J (1994) Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients. Arch Dermatol 130: 66–69

    PubMed  CAS  Google Scholar 

  • Ormerod LP, Horsfield N (1996) Frequency and type of reactions to antituberculous drugs: observations in routine treatment. Tuber Lung Disease 77: 37

    CAS  Google Scholar 

  • Pal PK (1999) Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol 39: 323–330

    PubMed  CAS  Google Scholar 

  • Pamphlett RS, MacKenzie RA (1982) Severe peripheral neuropathy due to lithium intoxication. J Neurol Neurosur Ps 45: 656

    CAS  Google Scholar 

  • Parry G, Bredesen D (1985) Sensory neuropathy with low dose pyridoxine. Neurology 35: 1466

    PubMed  CAS  Google Scholar 

  • Pedersen PB, Hogenhaven H (1990) Penicillamin-induced neuropathy in rheumatoid arthritis. Acta Neurol Scand 81: 188–190

    PubMed  CAS  Google Scholar 

  • Penn RG, Griffin JP (1982) Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland. Br Med J 284: 1440–1442

    Article  CAS  Google Scholar 

  • Phan T, McLeod JG, Pollard JD, Peiris O, Rohan A, Halpern J-P (1995) Peripheral neuropathy associated with simvastatin. J Neurol Neurosur Ps 58: 625–628

    CAS  Google Scholar 

  • Pool KD, Feit H, Kirkpatrick J (1981) Penicillamine-induced neuropathy in rheumatoid arthritis. Ann Intern Med 95: 457–458

    PubMed  CAS  Google Scholar 

  • Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ (1993) Long-term effects of vincristine on the peripheral nervous system. J Neurooncol 15: 23–27

    Article  PubMed  CAS  Google Scholar 

  • Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ (1995) Paclitaxel-induced neuropathy. Ann Oncol 6: 489–494

    PubMed  CAS  Google Scholar 

  • Quattrini A, Comi G, Nemni R, Martinelli V, Villa A, Caimi M, Wrabetz L, Canal N (1997) Axonal neuropathy associated with interferon-alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol 94: 504–508

    Article  PubMed  CAS  Google Scholar 

  • Ramirez JA, Mendell J, Warmolts J et al. (1986) Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol 19: 162

    Article  PubMed  CAS  Google Scholar 

  • Reinstein L, Ostrow SS, Wiernik PH (1980) Peripheral neuropathy after cis-platinum (II) (DDP) therapy. Arch Phys Med Rehabil 61: 280–282

    PubMed  CAS  Google Scholar 

  • Reliquet V, Mussini JM, Chennebault JM, Lafeuillade A, Raffi F (2001) Peripheral neuropathy during stavudine-didanosine antiretroviral therapy. HIV Med 2: 92–96

    Article  PubMed  CAS  Google Scholar 

  • Rhodes LE, Coleman MD, Lewis-Jones MS (1995) Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus. Clin Exp Dermatol 20: 155–156

    PubMed  CAS  Google Scholar 

  • Richardson PG, Barlogie B, Berenson J et al. (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348: 2609–2617

    Article  PubMed  CAS  Google Scholar 

  • Roelofs Rl, Hrushesky W, Rogin J, Rosenberg L (1984) Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34: 934–938

    PubMed  CAS  Google Scholar 

  • Rowinsky EK, Eisenhauer EA, Chaudry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Incol 20(Suppl 3): 1–15

    CAS  Google Scholar 

  • Sahenk Z, Brady ST, Mendell JR (1987) Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 10: 80–84

    Article  PubMed  CAS  Google Scholar 

  • Sahenk Z, Barohn R, New P, Mendell JR (1994) Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51: 726–729

    PubMed  CAS  Google Scholar 

  • Said G (1978) Perhexiline neuropathy: a clinicopathological study. Ann Neurol 3:259–266

    Article  PubMed  CAS  Google Scholar 

  • Scarsella A, Coodly G, Shalit P, Anderson R, Fisher RL, Liao Q, Ros LL, Hernandez JE (2002) Stavudine-associated peripheral neuropathy in zidovudine-naive patients: effect of stavudine exposure and antiretroviral experience. Adv Ther 19: 1–8

    PubMed  CAS  Google Scholar 

  • Schaumburg H, Kaplan J, Windeback A et al. (1983) Sensory neuropathy from pyridoxin abuse. New Engl J Med 309: 445–448

    Article  PubMed  CAS  Google Scholar 

  • Scheid W, Wieck HH, Stammler A, Kladetzky A, Gibbels E (1961) Polyneuritische Syndrome nach längerer Thalidomid-Medikation. Dtsch Med Wschr 86: 938–940

    PubMed  CAS  Google Scholar 

  • Seror P (1990) Sensitive neuropathy caused by almitrine. Rev Rhum Mal Osteoartic 57: 531–536

    PubMed  CAS  Google Scholar 

  • Shah RR, Oates NS, Idle JR, Smith RL, Lockhart JD (1982) Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J 284: 295–299

    CAS  Google Scholar 

  • Snider DE (1980) Pyridoxine supplementation during isoniazid therapy. Tubercle 61:191–196

    Article  PubMed  Google Scholar 

  • So E, Penry JK (1981) Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia 22: 467

    PubMed  CAS  Google Scholar 

  • Tambini R, Quattrini A, Fracassetti O, Nemni R (1997) Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 24:1656–1657

    PubMed  CAS  Google Scholar 

  • Tegner R, Tome FM, Godeau P, Lhermitte F, Fardeau M (1988) Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathol 75:253–260

    PubMed  CAS  Google Scholar 

  • Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JC (1984) Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54: 1269–1275

    PubMed  CAS  Google Scholar 

  • Tomkin GH (1973) Isonizid as a cause of neuropathy and sideroblastic anemia. Practitioner 211: 773

    PubMed  CAS  Google Scholar 

  • Tonkin EG, Erve JC, Valentine WM (2000) Disulfiram produces a non-carbon disulfide-de-pendent schwannopathy in the rat. J Neuropathol Exp Neurol 59: 786–797

    PubMed  CAS  Google Scholar 

  • Vanhooren G, Dehaene I, Van Zandycke M, Piessens F, Vandenbergh V, Van Hees J, Lammens M, Carton H (1990) Polyneuropathy in lithium intoxication. Muscle Nerve 13: 204–208

    Article  PubMed  CAS  Google Scholar 

  • Watson CP, Ashby P, Bilbao JM (1980) Disulfiram neuropathy. Can Med Assoc J 123: 123–126

    PubMed  CAS  Google Scholar 

  • Watkins SM, Griffin JP (1978) High incidence of vincristine-induced neuropathy in lympho-mas. Br Med J 11:610–612

    Google Scholar 

  • Weiss JJ, Thompson GR, Lazaro R (1982) Gold toxicity presenting as peripheral neuropathy. Clin Rheumatol 1: 285–289

    Article  PubMed  CAS  Google Scholar 

  • Wijesekera JC, Critchley EM, Fahim Y, Lynch PG, Wright JS (1980) Peripheral neuropathy due to perhexiline maleate. J Neurol Sci 46: 303–309

    Article  PubMed  CAS  Google Scholar 

  • Wulff CH, Hoyer H, Asboe-Hansen G, Bodthagen H (1985) Development of polyneuropathy during thalidomide therapy. Br J Dermatol 112: 475–480

    PubMed  CAS  Google Scholar 

  • Yoshikawa H, Abe T, Oda Y (1999) Extremely acute phenytoin-induced peripheral neuropathy. Epilepsia 40: 528–529

    Article  PubMed  CAS  Google Scholar 

  • Zampollo A, Sozzi G, Basso F (1988) Amitriptyline-related peripheral neuropathy. Case Report. Ital J Neurol Sci 9: 89–91

    PubMed  CAS  Google Scholar 

  • Ziajka PE, Wehmeier T (1998) Peripheral neuropathy and lipid-lowering therapy. South Med J 91:667–668

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik Helios-Kliniken Schwerin, Wismarsche Str. 393-397, 19049, Schwerin

    Prof. Dr. med. F. Block

  2. Institut für Neuropathologie des Universitätsklinikums Aachen, Pauwelsstr. 30, 52057, Aachen

    Prof. Dr. med. J. Weis

Authors
  1. Prof. Dr. med. F. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. J. Weis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Block, F., Weis, J. (2006). Periphere Neuropathie. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_17

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation